Ligne de temps
Giovanna Barba-Spaeth
Chef(fe) de Groupe
24 févr. 2024
publication
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.
Lire plus21 août 2023
publication
New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complex
Lire plus09 août 2023
08 mars 2023
02 févr. 2023
02 janv. 2023
publication
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
Lire plus22 juil. 2022
22 juil. 2022
14 juin 2022
publication
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
Lire plus01 avr. 2022
01 janv. 2022
publication
FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D.
Lire plus14 déc. 2021
publication
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.
Lire plus16 avr. 2021
publication
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.
Lire plus04 mars 2021
01 sept. 2020
project
Understanding protective humoral immunity in asymptomatic dengue-infected individuals
Lire plus01 mai 2020
publication
Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination.
Lire plus24 mars 2020
publication
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
Lire plus23 mai 2017
publication
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope.
Lire plus01 nov. 2016
publication
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Lire plus01 sept. 2016
publication
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Lire plus23 juin 2016
11 sept. 2015
11 mai 2015
02 avr. 2015
publication
Recognition determinants of broadly neutralizing human antibodies against dengue viruses.
Lire plus15 mai 2011
publication
Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
Lire plus23 juin 2010
publication
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.
Lire plus01 déc. 2006
publication
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Lire plus31 oct. 2005
publication
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
Lire plus17 janv. 2005
publication
Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.
Lire plus01 févr. 2002
publication
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.
Lire plus01 oct. 1999
publication
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates.
Lire plus01 mai 1999
publication
Permissiveness of human biliary epithelial cells to infection by hepatitis C virus.
Lire plus18 févr. 1997
publication
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.
Lire plus01 oct. 1994
publication
A new PCR-based typing of the Rodgers and Chido antigenic determinants of the fourth component of human complement.
Lire plus01 juil. 1994
publication
Polymorphism of the complement C8A and -B genes in two families with C8 beta deficiency and neisserial infections.
Lire plus01 avr. 1993
publication
Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression.
Lire plus05 juil. 1990
01 janv. 1990
publication